calendar
13,309 catalysts · 3,603 8k filing · 2,401 grant · 2,049 approval · 1,383 device 510k · 1,000 device adverse event · 931 device pma
13,309 catalysts · 3,603 8k filing · 2,401 grant · 2,049 approval · 1,383 device 510k · 1,000 device adverse event · 931 device pma
Sponsor: SOMERSET THERAPS LLC. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: GRANULES. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: ELITE LABS INC. Form: TABLET. Route: ORAL
Sponsor: SOMERSET THERAPS LLC. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: AVANTHI INC. Form: TABLET. Route: ORAL
Sponsor: QUAGEN. Form: TABLET. Route: ORAL
Sponsor: SOMERSET THERAPS LLC. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: MIKART. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: MIKART. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: HOSPIRA INC. Form: INJECTABLE. Route: INJECTION
Sponsor: INTL MEDICATION SYS. Form: INJECTABLE. Route: INJECTION
Sponsor: INTL MEDICATION SYS. Form: INJECTABLE. Route: INJECTION
Sponsor: GRANULES. Form: TABLET. Route: ORAL
Sponsor: STEVENS J. Form: CAPSULE. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: TREVENA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BDSI. Form: FILM. Route: BUCCAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: ETHYPHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: AMNEAL PHARMS. Form: SYRUP. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SYRUP. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION